Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome-Reference-Cited by-同舟云学术

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

Published:2014-01 Issue:1 Volume:4 Page:e177-e177
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Chen T-C,Hou H-A,Chou W-C,Tang J-L,Kuo Y-Y,Chen C-Y,Tseng M-H,Huang C-F,Lai Y-J,Chiang Y-C,Lee F-Y,Liu M-C,Liu C-W,Liu C-Y,Yao M,Huang S-Y,Ko B-S,Hsu S-C,Wu S-J,Tsay W,Chen Y-C,Tien H-F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201374.pdf

Reference42 articles.

1. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.

2. Hofmann WK, Koeffler HP . Myelodysplastic syndrome. Annu Rev Med 2005; 56: 1–16.

3. Acquaviva C, Gelsi-Boyer V, Birnbaum D . Myelodysplastic syndromes: lost between two states? Leukemia 2010; 24: 1–5.

4. Kulasekararaj AG, Mohamedali AM, Mufti GJ . Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes. Br J Haematol 2013; 162: 587–605.

5. Bejar R, Levine R, Ebert BL . Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011; 29: 504–515.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119;Blood Cancer Discovery;2024-02-14

2. SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis;Leukemia;2023-11-28

3. Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients;Leukemia Research;2023-01

4. Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome;Hematological Oncology;2022-11-09

5. Role of ASXL1 in hematopoiesis and myeloid diseases;Experimental Hematology;2022-11